Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
904K
-
Shares change
-
+77.3K
-
Total reported value, excl. options
-
$2.16M
-
Value change
-
+$185K
-
Number of buys
-
7
-
Number of sells
-
-8
-
Price
-
$2.39
Significant Holders of Dare Bioscience, Inc. - COM NEW (DARE) as of Q2 2025
26 filings reported holding DARE - Dare Bioscience, Inc. - COM NEW as of Q2 2025.
Dare Bioscience, Inc. - COM NEW (DARE) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 904K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (328K shares), AMH Equity Ltd (194K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (107K shares), GEODE CAPITAL MANAGEMENT, LLC (95.5K shares), RENAISSANCE TECHNOLOGIES LLC (71.8K shares), STATE STREET CORP (23.5K shares), BlackRock, Inc. (17K shares), COMMONWEALTH EQUITY SERVICES, LLC (16.7K shares), UBS Group AG (15K shares), and NORTHERN TRUST CORP (15K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.